Edition:
India

Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

13.40USD
16 Aug 2019
Change (% chg)

$0.93 (+7.46%)
Prev Close
$12.47
Open
$12.52
Day's High
$13.42
Day's Low
$12.48
Volume
377,089
Avg. Vol
243,191
52-wk High
$16.38
52-wk Low
$2.62

About

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. Adverum has a robust pipeline that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (A1AT) deficiency and hereditary angioedema (HAE) as well as wet age-related... (more)

Overall

Beta: --
Market Cap(Mil.): $153.67
Shares Outstanding(Mil.): 43.29
Dividend: --
Yield (%): --

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates